Strategic Growth Series - Using Electronic Health Data to Address Questions of Clinical Utility and Economic Value for Medical Devices
Med Tech companies are facing challenges in commercializing their innovative products and increasingly need to demonstrate clinical utility and economic value to obtain coverage and reimbursement. Providers are assuming greater financial risk for patient care as payers move away from service-based reimbursement towards more bundled and population-based payments. Electronic health data (medical records, lab information, patient reported outcomes, claims, etc.) are a valuable source of tracking patient outcomes and costs and reporting on quality indicators.
Marianne Laouri, Ph.D. - Specialist Leader Life Sciences Strategy and Operations, Deloitte Consulting LLP
Jan Hansen, Ph.D – VP Global Health Outcomes, Allergan
Lynda Gibson – Director, Business Intelligence, Deloitte Consulting LLP
Anwer Khan – Director, Life Sciences Information Management & Business Analytics, Deloitte Consulting LLP